Karyopharm Therapeutics

KPTINasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$48.045 M

$2.12 +8.72%

Close of 7 Aug 2026

Revenue

$146.1M

#2408 by revenue

Earnings

-$196.0M

Loss-making

Shares outstanding

22,662,943

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#352Seres TherapeuticsMCRB$48.4M
#353Filana TherapeuticsFLNA$48.1M
#354Karyopharm TherapeuticsKPTI$48.0M
#355Impact BiomedicalIBO$46.9M
#356Edesa BiotechEDSA$46.9M

Where these numbers come from

Share counts and financials for Karyopharm Therapeutics are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.